SIROLIMUS vs SUTENT

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. SIROLIMUS and SUTENT are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	SIROLIMUS	SUTENT
Rating	66/100	New
Pharmacy pays	~$48.61 /30	—
Type	RX	RX
Active ingredient	SIROLIMUS	SUNITINIB MALATE
Manufacturer	Apotex	Cppi Cv
Dosage forms	Solution	Capsule
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	Boxed warning	Boxed warning
Treats	Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms	Renal Cell Carcinoma, Pancreatic Neoplasms, Neuroendocrine Tumors

sirolimus sutent

Rating

66/100

New

Pharmacy pays

~$48.61 /30

—

Type

Active ingredient

SIROLIMUS

SUNITINIB MALATE

Manufacturer

Apotex

Cppi Cv

Dosage forms

Solution

Capsule

Drug class

Kinase Inhibitor

Boxed warning

Treats

Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms

Renal Cell Carcinoma, Pancreatic Neoplasms, Neuroendocrine Tumors

Frequently asked questions

What is the difference between Sirolimus and Sutent?

Sirolimus contains Sirolimus, while Sutent contains Sunitinib Malate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.